The Altasciences Group has partnered with Vince and Associates Clinical Research to provide comprehensive Phase I/IIa drug development services. Vince and Associates specializes in the recruitment and retention of special populations in complex early development clinical trials.
 
“We continue to benefit from the industry shift towards these types of complex studies and joining the Altasciences team will significantly enhance our capabilities while allowing us to continue the responsive delivery of quality research data to our global biopharmaceutical clients,” said Dr. Brad Vince, founder, president and medical director of Vince and Associates. Dr. Vince will continue to serve as chief executive officer and medical director.